Mainka & Dietze
wir über uns
Home
Aktuelles
Wir über uns
  Ärzte
Team
Diagnostik
Therapie
Studien
Praxis Porz
Praxis Kalk
Kooperationen
Zertifikate
Tumorarten
Anfahrt
Kontakt
Impressum
Publikationsliste – Achim Rothe
  1. Shimabukuro-Vornhagen, A., Draube, A., Liebig, T.M., Rothe, A., Kochanek, M., von Bergwelt-Baildon, M.S.., The immunosuppressive factors IL-10, TGF-beta, and VEGF do not affect the antigen-presenting function of CD40-activated B cells. J Exp Clin Cancer Res. 2012 May 16;31(1):47.
  2. Gopal, A.K., Ramchandren, R., O’Connor, O.A., Berryman, R.B., Advani, R.H. Chen, R., Smith, S.E., Cooper, M., Rothe, A., Matous, J., Grove, L.E., Zain, J., Safety and Efficacy of Brentuximab Vedotin for Hodgkin Lymphoma recurring after allogeneic transplant. Blood. 2012 Apr 17.
  3. Shimabukuro-Vornhagen A, Rothe A, Nogova L, Kochanek M, Scheid C, von Bergwelt-Baildon M. Improvement of platelet dysfunction in chronic myelogenous leukemia following treatment with imatinib: a case report. J Med Case Reports. 2011 May 30;5:215.
  4. Jachimowicz RD, Fracasso G, Yazaki PJ, Power BE, Borchmann P, Engert A, Hansen HP, Reiners KS, Marie M, von Strandmann EP, Rothe A. Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinoma. Mol Cancer Ther. 2011 Jun;10(6):1036-45. Epub 2011 Apr 27.
  5. Rothe A, Rubbert A. Recombinant proteins in rheumatology - recent advances. N Biotechnol. 2011 Sep;28(5):502-10. Epub 2011 Apr 5.
  6. Rothe, A., Power, B.E., Hudson, P.J., Therapeutic advances in rheumatology with the use of recombinant proteins. Nat Clin Pract Rheumatol. 2008 Nov;4(11):605-14. Epub 2008 Sep
  7. Rothe, A., Nathanielsz, A., Oberhäuser, F., Pogge von Strandmann, E., Engert, A., Hudson, P.J., Power, B. E., Selection of human anti-CD22 scFvs from an acute lymphocytic leukemia related scFv library with ribosome display. Biol Chem. 2008 Apr;389(4):433-9.
  8. Rothe A., Nathanielsz A., Hosse R.J., Oberhäuser F., Pogge von Strandmann E., Engert A., Hudson P.J.and Power B.E., Selection of human anti-CD28 scFvs from a T-NHL related scFv library using ribosome display. J Biotechnol. 2007 Jul 15;130(4): 448-54. Epub 2007 May 24.
  9. Pogge von Strandmann, E., Simhadri, V.R., von Tresckow, B., Sasse, S., Reiners, K.S., Hansen, H.P., Rothe, A., Böll, B., Simhadri, V.L., Borchmann, P., McKinnon, P.J., Hallek, M., and Engert., A., Human Leukocyte Antigen-B-Associated Transcript 3 Is Released from Tumor Cells and Engages the NKp30 Receptor on Natural Killer Cells. Immunity, 2007. 27(6): p. 965-74.
  10. Rothe, A., R.N. Surjadi, and B.E. Power, Novel proteins in emulsions using in vitro compartmentalization. Trends Biotechnol, 2006. 24(12): p. 587-92.
  11. Rothe A., Hosse R.J. and Power B.E., In vitro display technologies reveal novel BioPharmaceutics. Faseb J, 2006. 20(10):1599-610.
  12. 22. Hosse R.J., Rothe A. and Power B.E., Recombinant Proteins for Research, Diagnosis and Therapy, Diversified, Selected and Fine-tuned. Bioforum Europe, May 2006.
  13. Rothe A., Hosse R.J. and Power B.E., Ribosome display for improved biotherapeutic molecules. Expert Opin Biol Ther. 2006 Feb;6(2):177-87.

    << Zurück Weiter >>
MVZ West GmbH
Standort Köln-Kalk und
Standort Köln-Porz
Datenschutzerklärung
Buchforststr. 14 / 51103 Köln-Kalk
Urbacher Weg 19 / 51149 Köln-Porz
Tel.: 0221/872047
Tel.: 02203/699400
http://www.mainkadietzerothe.de
Email: info@mainkadietzerothe.de